Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11707532 Compositions and methods of treating muscle dystrophy

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 26 Jul, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 26 Jul, 2023
Edits made to:
Infobox (+78 properties)
Article (+126 characters)
‌

 US Patent 11707532 Compositions and methods of treating muscle dystrophy

Article

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle dystrophy (DM1).

Infobox
Is a
Patent
Patent
0
Patent Applicant
Avidity Biosciences
Avidity Biosciences
0
Current Assignee
Avidity Biosciences
Avidity Biosciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
117075320
Date of Patent
July 25, 2023
0
Patent Application Number
178183190
Date Filed
August 8, 2022
0
Patent Citations
‌
US Patent 7244724 Pyrrolobenzodiazepines
0
‌
US Patent 7250496 Bioinformatically detectable group of novel regulatory genes and uses thereof
0
‌
US Patent 7276497 Cytotoxic agents comprising new maytansinoids
0
‌
US Patent 11179472 Nucleic acid-polypeptide compositions and methods of inducing exon skipping
0
‌
US Patent 7452987 Interfering RNA molecules
0
‌
US Patent 7498298 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 7528126 Pyrrolobenzodiazepines
0
‌
US Patent 7612062 Pyrrolobenzodiazepines
0
‌
US Patent 7659241 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
0
‌
US Patent 7691997 Functional and hyperfunctional siRNA
0
‌
US Patent 7704924 Library of compounds comprising pyrrolobenzodiazepine moieties
0
‌
US Patent 7709226 Method of humanizing antibodies by matching canonical structure types CDRs
0
‌
US Patent 7750116 Antibody drug conjugate metabolites
0
‌
US Patent 7833992 Conjugates and compositions for cellular delivery
0
‌
US Patent 7850975 Chemically programmable immunity
0
‌
US Patent 7893245 Interfering RNA molecules
0
‌
US Patent 7923547 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 7943762 Oligonucleotide analogs having cationic intersubunit linkages
0
‌
US Patent 7964566 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 8084598 Bioionformality detectable group of novel regulatory oligonucleotides and uses thereof
0
‌
US Patent 8090542 Functional and hyperfunctional siRNA
0
‌
US Patent 8163736 Cytotoxic agents comprising new tomaymycin derivatives
0
‌
US Patent 8202979 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
0
‌
US Patent 8273866 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)
0
‌
US Patent 8288352 Auristatins having an aminobenzoic acid unit at the N terminus
0
‌
US Patent 8324370 Interfering RNA molecules
0
‌
US Patent 8404678 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
0
‌
US Patent 8426402 Benzodiazepine derivatives
0
‌
US Patent 8501934 Pyrrolobenzodiazepines
0
‌
US Patent 8580820 Tubulysin compounds with high cytotoxicity, pharmaceutical compositions thereof, and method of use thereof
0
‌
US Patent 8591910 Chemically programmable immunity
0
‌
US Patent 8604184 Chemically programmable immunity
0
‌
US Patent 8609105 Auristatin drug linker conjugates
0
‌
US Patent 8618277 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 8633185 Pyrrolobenzodiazepines
0
‌
US Patent 8648185 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 8697688 Pyrrolobenzodiazepines used to treat proliferative diseases
0
‌
US Patent 8703714 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 8802667 Benzodiazepine derivatives
0
‌
US Patent 8809320 Benzodiazepine derivatives
0
‌
US Patent 8835402 Compound and method for treating myotonic dystrophy
0
‌
US Patent 8871720 Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
0
‌
US Patent 8933215 Interfering RNA molecules
0
‌
US Patent 8936910 Method for selective oligonucleotide modification
0
‌
US Patent 8980833 Tubulysine derivatives
0
‌
US Patent 9089614 Hydrophilic self-immolative linkers and conjugates thereof
0
‌
US Patent 9181551 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 9222092 Interfering RNA molecules
0
‌
US Patent 9242013 Targeted pyrrolobenzodiazapine conjugates
0
‌
US Patent 9260471 RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
0
‌
US Patent 9605019 Methods for the synthesis of functionalized nucleic acids
0
‌
US Patent 9657294 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 9695211 Method for the synthesis of phosphorus atom modified nucleic acids
0
‌
US Patent 9695423 Interfering RNA molecules
0
‌
US Patent 9732344 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 9765338 Modulation of dystrophia myotonica-protein kinase (DMPK) expression
0
‌
US Patent 9771588 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 9796974 Modified RNAi agents
0
‌
US Patent 9890379 Treatment of genetic disorders associated with DNA repeat instability
0
‌
US Patent 9982257 Chiral control
0
‌
US Patent 10000754 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 10323089 Anti-transferrin receptor antibodies with tailored affinity
0
‌
US Patent 10881743 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
‌
US Patent 10913800 Anti-transferrin receptor antibodies and uses thereof
0
‌
US Patent 10994020 Nucleic acid-polypeptide compositions and methods of inducing exon skipping
0
‌
US Patent 11028179 Anti-transferrin receptor antibodies and uses thereof
0
‌
US Patent 11246941 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
‌
US Patent 11253607 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
‌
US Patent 11446387 Compositions and methods of treating muscle dystrophy
0
Patent Primary Examiner
‌
Phuong Huynh
0

Find more entities like US Patent 11707532 Compositions and methods of treating muscle dystrophy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo